 |
|
|
| |
Combination of an Acetyl-CoA Carboxylase Inhibitor and
Fibroblast Growth Factor-19 Reduced Tissue Triglyceride
Content and Fibrosis in a 3D Human Liver Microtissue
Model of Nonalcoholic Steatohepatitis
|
| |
| |
AASLD 2021 Nov 12-15
Wen-Wei Tsai,1 Manuela Bieri,2 Sue Grepper,2 Eva Thoma,2 James L. Trevaskis1 - 1Gilead Sciences Inc., Foster City, CA; 2InSphero AG, Schlieren, Switzerland
|
| |
|
|
|
|
|
